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S1. Data
The sampling protocol for the lions and dog datasets were described in Viana et al. 2015
[0]. Below we provide a brief description of this protocol, including differences in sample
selection criterion for the dogs.
Lion data
Lion populations in the Serengeti National Park and Ngorongoro Conservation Area have
been continuously monitored by the Serengeti Lion Project since 1966. Most lions included
in this study have been observed since birth and are recognised from natural markings
and whisker-spot patterns [1-3]. Consequently, their date of birth is known. For unknown
lions, sampled as part of other interventions (such as snare removal), ages were estimated
on the basis of nose coloration [4].
Serum samples for serological testing were opportunistically collected as part of the
Serengeti National Park management or research interventions (e.g. fitting/removing
radio-collars, snare removals and wound treatment; [5]) led by Tanzania National Parks
and Tanzania Wildlife Research Institute and Ngorongoro Conservation Area Authority.
To maximise samples and ensure independence of observations, if a lion was sampled mul-
tiple times and all samples tested positive for canine parvovirus (CPV) antibodies, only
the first sample was included in the analyses. Conversely, if all samples were seronegative,
only the last sample was included. Finally, if the first sample was seronegative but the
second was seropositive, we included both samples in the analysis but the birth year cor-
responding to the second sample was considered to be the sample year of the first sample.
Table S1 contains the number of samples included in the analyses.
Dog data
Domestic dog populations surrounding the Serengeti National Park have been intensively
studied since the early 1990s and serological surveys have been conducted since 1992.
Dogs were sampled during central-point and house-to-house vaccination campaigns [6]
and, in unvaccinated areas, during randomised household surveys. At the time of sam-
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pling, information on the age of each dog sampled is obtained by questioning the owner.
Previous longitudinal studies in East Africa demonstrated that owner-reported ages are
reliable when evaluated as part of specific research studies [7-8]. The reliability of ages
recorded during routine vaccination campaigns is likely to be less certain. The dog sam-
pling protocol is described in [9] and the vaccination coverage is shown in Fig. S1.
To ensure that only data from unvaccinated dogs were analysed, we included only dogs
from villages that had never been vaccinated and dogs from vaccinated villages that were
i) sampled before the onset of vaccination in a given village; or ii) born after the previ-
ous vaccination campaign. Given that dogs in vaccinated areas receive vaccination also
against rabies and canine distemper virus (CDV), for dogs older than 1 year and originat-
ing from vaccinated areas, sera were also tested for antibodies against rabies and CDV.
Dogs that had a negative antibody titre against at least one of the three pathogens were
considered unvaccinated and included in the analyses. Very young pups (0 - 3 months)
were excluded from the analyses to avoid misclassification of CPV status due to possible
maternal antibodies. Following this pre-selection that ensured all dogs were unvaccinated,
because CPV vaccine can shed and be acquired by unvaccinated susceptible dogs, for the
CPV modelling we further restrict the dog samples to those from which information about
village vaccination coverage was available for the year of sampling. Table S1 contains the
number of samples available and included in the analyses and Fig. 2 shows the seropreva-
lence over time in dogs and lions.
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Figure S1: Proportion of dogs vaccinated during time in the sampled villages only (blue),
in the whole Serengeti National Park region (red) and in the western part of the region
(black).
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Table S1: Number of serum samples from Ngorongoro and Serengeti lions and unvacci-
nated domestic dogs sampled in areas surrounding the Serengeti National Park available
for canine parvovirus serology. Dog sample sizes are also subdivided depending on whether
the dog originated from an unvaccinated or vaccinated village and the sample size used
in the CPV state-space modelling.
Non-vaccinated domestic dogs
Year Lions Total
Non-vaccinated
villages
Vaccinated
villages
Dogs used in
CPV models
1984 12 - - - -
1985 36 - - - -
1986 7 - - - -
1987 26 - - - -
1988 1 - - - -
1989 12 - - - -
1990 2 - - - -
1991 19 - - - -
1992 4 223 223 - -
1993 8 155 155 - -
1994 56 240 240 - -
1995 - - - - -
1996 1 181 180 1 178
1997 15 643 458 185 298
1998 28 921 658 263 398
1999 10 486 455 31 -
2000 17 90 23 67 45
2001 21 250 134 116 -
2002 11 151 19 132 -
2003 29 550 508 42 422
2004 32 1073 586 487 350
2005 37 403 35 368 164
2006 29 672 188 484 282
2007 17 307 12 295 26
2008 6 84 - 84 62
2009 4 157 - 157 66
2010 6 133 - 133 99
2011 11 72 - 72 58
2012 1 75 - 75 -
Total 458 6866 3874 2992 2368
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Serological assays
All CPV serology was carried out using neutralisations assays. Sera were analysed at In-
tervet UK, Animal Health Diagnostic Center at Cornell (New York, USA) and University
of Glasgow (UK). Protocols were broadly similar in all laboratories, including viral strains
used for the assay. We used a cut-off titer value equivalent to a 1:16 dilution to evaluate
prior exposure. This value was the minimum dilution consistently used across all samples
and is consistent with other studies of CDV exposure in wild carnivore species [9-11]. Sera
from older dogs originating from vaccinated areas and with uncertain vaccination status
were additionally tested for antibodies against rabies and CPV (see above). Antibody
titres for CPV were determined by hemagglutination inhibition (HAI) testing [12] at In-
tervet (United Kingdom) and the Animal Health Diagnostic Center (Cornell University,
Ithaca, NY). Dog CPV serology from samples collected from 2008 to 2012 was carried out
using ELISAs (IgG) at the University of Glasgow.
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Figure S2: Canine distemper virus (light grey), dogs canine parvovirus (grey) and li-
ons CPV (blue) observed seroprevalence over time, the vertical lines correspond to the
standard error.
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S2. Serology models
The methodology largely follows from Viana et al 2015 [0]. Briefly we use two Bayesian
state-space models. They disentangle the natural from the vaccine acquired CPV immu-
nity but model 1 is used to (i) characterize the within and between-species dynamics of
CPV natural infection in dogs and lions; and (ii) quantify the impact of the vaccination
programs on those infection dynamics; and model 2 to (iii) investigate the co-infection
dynamics between CPV and CDV in domestic dogs in the Serengeti from serology data
and vaccination history of each individual. Briefly, the models are all composed of two
parts: i) a Biological process which characterises the mechanism of infection; and ii) an
Observation process which confronts the processes underlying the generation of the ob-
served data (mostly at the population level) with the individual level data. Ultimately,
the state-space model describes the combination of stochastic processes giving rise to the
data in Figure S2.
Biological process
1. Dynamics of CPV at the domestic-wildlife interface and effect of vaccination in dogs
We are interested in estimating, hs(t), the proportion of infected individuals of species
s at year t, where t ranges from 1 to 39 and corresponds to a time series from 1973
(corresponding to the earliest birth date of an individual) to 2012 (last sampling year).
Here, this proportion is defined through a logit transformation such that:
hs(t) =
exp(Hs(t))
1 + exp(Hs(t))
(1)
where Hs(t) is the predictor of hs(t), defined as a stochastic realisation from a Gaussian
process:
Hs(t) ∼ N(H¯s(t), σs,t) (2)
The variability σs,t corresponds to the annual variation around the expectation H¯s(t). The
prior distribution for σs,t is defined in Table S2. H¯s(t) is formulated as a linear function
of covariates that describe the CPV transmission process in domestic dogs and lions. In
their most parameterised forms, the expected predictor for dogs and lions were:
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H¯lions,t = β0 + β1t+ β2Hlions,t−1 + β3Hlions,t−2 + β4Hdogs,t−1 (3)
H¯dogs,t = ω0 + ω1t+ ω2Hdogs,t−1 + ω3Hdogs,t−2 + ω4Hlions,t−1 − ω5Ct−1 (4)
The parameters β0 and ω0 corresponding to the intercept, which is the baseline probability
of infection, while the coefficient β1 and ω1 correspond to the coefficient of a linear trend
on time. The coefficients β2, β3, ω2 and ω3 for the dogs and the lions correspond to the
coefficients of an autoregressive component (AR) with lag 1 and 2, respectively. The AR
terms were used to emulate the disease dynamics as they enable the generation of persis-
tent cycles in the infection dynamics. Given that the questions we ask are at an annual
scale, the magnitude of these AR components are thought to be appropriate. The pa-
rameters β4 for the lions and ω4 for the dogs correspond to the cross-species transmission
coefficients , and are defined as an autoregression of lag 1 on the probability of infection
of the other species (i.e. β4 corresponds to the transmission from dogs to lions and ω4
to the transmission from lions to dogs). The difference between the lion and dog linear
predictors is that the dogs might be directly affected by vaccination. Thus the impact of
regional vaccination coverage (Ct) on the domestic dog annual CPV seroprevalence was
then included as a lagged covariate with coefficient ω5.. The priors for all these coefficients
are defined in Table S2. When needed we constrained the priors to be biologically plau-
sible. For example, the priors for the vaccination parameters were described as strictly
positive since vaccination cannot increase infectivity. Owing to the AR lags, priors drawn
from a normal distribution with mean ω0 and variance 10
3 were allocated to the first two
time points, H¯t=1,2.
At the individual level, the probability of an individual i of species s becoming infected
at time t, denoted ui,s(t), is defined as:
ui,s(t) =
exp(Ui,s(t)
1 + exp(Ui,s(t))
(5)
where Ui,s(t) is the predictor of ui,s(t) and is modelled as a Gaussian term such that:
Ui,s(t) ∼ N(U¯i,s(t), ψi,s,t) (6)
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The stochasticity generated by ψ is the expression of individual variation which increases
with the duration of the time interval between the years of birth and sampling; i.e. the
uncertainty in the time of exposure of an individual with a greater time interval between
birth and sampling will be higher than one with a short interval. The prior distribution
for ψi,s,t is defined in Table S2. U¯i,s(t) is defined as:
U¯i,lions(t) = Hi,lions(t) + s,i,t (7)
U¯i,dogs(t) = Hi,dogs(t) + v1Vi,t + s,i,t (8)
The error term  enables additional individual uncertainty for species s, individual i at
time t. For dogs, U¯i,dogs(t) also takes into account vaccine shedding and is here that the
natural infection can be disentangled from the vaccine acquired ”infection”. The coeffi-
cient v1 represents the rate governing the impact of the village-level vaccination coverage
(V ) on the probability of infection of a dog. The prior for this parameter is defined in
Table S2.
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Table S2: Prior distributions for the parameters used to model the lion and domestic
dog populations annual probability of canine parvovirus infection. AR corresponds to the
autoregression.
Species Variable Parameter Distribution Prior
Lions Correct detection q+ Beta ∼ beta(25, 0.5)
False detection q− Beta ∼ beta(0.5, 25)
Variance ψ|σ Normal ∼ N(0, τ 2−1)
Standard deviation τ Uniform ∼ U(0, 5)
Intercept β0 Normal ∼ N(0, 0.001)
Linear trend β1 Normal ∼ N(0, 0.001)
AR(1) β2 Normal ∼ N(0, 0.1)
AR(2) β3 Normal ∼ N(0, 0.1)
Dog-to-lion transmission β4 Exponential ∼ exp(0.5)
Dogs Correct detection q+ Beta ∼ beta(25, 0.5)
False detection q− Beta ∼ beta(0.5, 25)
Variance ψ|σ Normal ∼ N(0, τ 2−1)
Standard deviation τ Uniform ∼ U(0, 5)
Village status (lag 1) v1 Exponential ∼ exp(0.5)
Village status (lag 2) v2 Exponential ∼ exp(0.5)
Intercept ω0 Normal ∼ N(0, 0.001)
Linear trend ω1 Normal ∼ N(0, 0.001)
AR(1) ω2 Normal ∼ N(0, 0.1)
AR(2) ω3 Normal ∼ N(0, 0.1)
Lion-to-dog transmission ω4 Exponential ∼ exp(0.5)
Regional vacc. (lag 1) ω5 Exponential ∼ exp(0.5)
Shedding parameter v1 Beta ∼ beta(3, 12)
*Normal distributions are expressed in terms of mean and precision.
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3. Co-infection patterns between CPV and CDV in dogs
Finally, we are here interested in estimating, hd(t), the proportion of dogs infected infected
by the disease d at year t, where t ranges from 1 to 27 and corresponds to a time series from
1992 to 2008. The disease d can be either CPV, CDV, or another term called “both”,
corresponding to the proportion of dogs infected by CPV and CDV at the same time.
Again, this proportion is defined through a logit transformation such that:
hd(t) =
exp(Hd(t))
1 + exp(Hd(t))
(9)
where Hs(t) is the predictor of hd(t), defined as a stochastic realisation from a Gaussian
process:
Hd(t) ∼ N(H¯d(t), σd,t) (10)
In their most parameterised forms, the expected predictor for CPV, CDV and both were:
H¯CPV,t = β0 + β1t+ β2HCPV,t−1 + β3HCPV,t−2 + β4HCDV,t−1 − β5Ct−1 (11)
H¯CDV,t = ω0 + ω1t+ ω2HCDV,t−1 + ω3HCDV,t−2 + ω4HCPV,t−1 − ω5Ct−1 (12)
H¯both,t = γ0HCPV,tHCDV,t + γ1HCPV,t−1HCDV,t + γ2HCPV,tHCDV,t−1 (13)
The parameters β0 and ω0 corresponding to the intercept, the coefficient of a linear trend
on time (β1 and ω1), the autoregressive components (β2, β3, ω2 and ω3) are similar to the
ones defined in equations (6), (9) and (10), respectively for CPV and CDV. The parame-
ters β4 for CPV and ω4 for CDV correspond to the influence of a disease on the other, and
are defined as an autoregression of lag 1 on the probability of infection by the other disease
(i.e. β4 corresponds to the increase of probability of a dog being infected by CPV if it was
infected by CDV at t-1 and reciprocally for ω4). Because we don’t see an effect of the lag
2 vaccination terms, we reduced the required computation time to run the model by only
considering the vaccination terms with a 1-year lag for CDV and CPV. The parameter γ0
corresponds to a term of independence: if the two diseases have independent dynamics,
then the probability of being infected by both at time t is the product HCPV,tHCDV,t.
γ1 corresponds to the effect of CPV infection on the coinfection with a 1-year lag, while
gamma2 corresponds to the effect of CDV infection on the coinfection, also with a 1-year
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time-lag. The priors for all these coefficients are defined in Table S3.
At the individual level, the probability of an individual i of species s becoming infected
at time t, denoted ui,s(t), is defined as:
ui,s(t) =
exp(Ui,d(t)
1 + exp(Ui,d(t))
(14)
where Ui,d(t) is the predictor of ui,d(t) and is modelled as a Gaussian term such that:
Ui,d(t) ∼ N(U¯i,d(t), ψi,d,t) (15)
The prior distribution for ψi,d,t is defined in Table S4. U¯i,d(t) is defined as:
U¯i,CPV (t) = Hi,CPV (t) + v1Vi,t (16)
U¯i,CDV (t) = Hi,CDV (t) (17)
U¯i,both(t) = Hi,both(t) (18)
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Table S3: Prior distributions for the parameters used to model the lion and domestic dog
populations annual probability of canine distemper virus infection. AR corresponds to
the autoregression.
Disease Variable Parameter Distribution Prior
CPV Correct detection q+ Beta ∼ beta(25, 0.5)
False detection q− Beta ∼ beta(0.5, 25)
Variance ψ|σ Normal ∼ N(0, τ 2−1)
Standard deviation τ Uniform ∼ U(0, 5)
Intercept β0 Normal ∼ N(0, 0.001)
Linear trend β1 Normal ∼ N(0, 0.001)
AR(1) β2 Normal ∼ N(0, 0.1)
AR(2) β3 Normal ∼ N(0, 0.1)
CDV-to-CPV transmis-
sion
β4 Normal ∼ N(0, 0.1)
Regional vacc. (lag 1) β5 Normal ∼ N(0, 0.01)
Shedding parameter v1 Beta ∼ beta(3, 12)
CDV Correct detection q+ Beta ∼ beta(25, 0.5)
False detection q− Beta ∼ beta(0.5, 25)
Variance ψ|σ Normal ∼ N(0, τ 2−1)
Standard deviation τ Uniform ∼ U(0, 5)
Intercept ω0 Normal ∼ N(0, 0.001)
Linear trend ω1 Normal ∼ N(0, 0.001)
AR(1) ω2 Normal ∼ N(0, 0.1)
AR(2) ω3 Normal ∼ N(0, 0.1)
CPV-to-CDV transmis-
sion
ω4 Normal ∼ N(0, 0.1)
Regional vacc. (lag 1) ω5 Normal ∼ N(0, 0.01)
Both Correct detection q+ Beta ∼ beta(25, 0.5)
False detection q− Beta ∼ beta(0.5, 25)
Variance ψ|σ Normal ∼ N(0, τ 2−1)
Standard deviation τ Uniform ∼ U(0, 5)
Independent infections γ0 Normal ∼ N(0, 0.1)
CPV-to-coinfection γ1 Normal ∼ N(0, 0.1)
CPV-to-coinfection γ2 Normal ∼ N(0, 0.1)
*Normal distributions are expressed in terms of mean and precision.
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Observation process
In this section, we describe the observation process corresponding to the domestic-wildlife
interface model. The observation processes corresponding to the co-infection model are
defined the same way.
Assuming that the ith individual of species s was born in year ti and was sampled in year
Ti, the probability ri,s(Ti) that, at sampling, it was in fact seropositive is:
ri,s(Ti) = 1−
Ti∏
t=ti
(1− ui,s(t)) (19)
where, ui,s(t) is the probability of individual i, of species s, becoming infected at time
t as described above in equations (3-4). This probability links the observation process
at the individual level with the biological process at the population level. We estimate
the likelihood of being infected between birth and sampling years because it is impos-
sible to identify the exact time of exposure from a serology test. Once an individual is
infected and recovers from CDV it gains life-long immunity, hence, after infection, the
individual will always test positive in the serology assay. This means that the time-series
investigated starts in the year when the first individual from both species was born, i.e.
1970; and ends in the last year for which data are available, i.e. 2012. As a conse-
quence, larger uncertainty should be expected in the initial years of the time-series when
no samples, hence no serological data, were available, but the first lions were already born.
In addition to the inherent difficulty in detecting antibodies, test results from serological
assays are typically sensitive to cut-off thresholds [13]. This means that the true disease
status of an individual does not always correspond to the test result. In order to account
for this potential misclassification of the animal disease status, in Table S4 we introduce
probabilities of Type I and Type II errors.
The likelihood that an individual i is detected as seropositive (P (Xi = 1)) or seronegative
(P (Xi = 0)) is based on serology data X and was defined in our model as:
P (Xi = 1) = ri,s(Ti)q
+ + (1− ri,s)(1− q−) (20)
P (Xi = 0) = ri,s(Ti)(1− q+) + (1− ri,s)q− (21)
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Table S4: Probabilities (q) associated with canine distemper virus serological misclassifi-
cation.
True state
+ -
Test + q+ 1−q−
result - 1−q+ q−
Based on serological literature [13], we expect high correct detection (q) and low false
detection (1− q). See Table S3 for further details on these priors.
The total likelihood of the data X under the model and parameters was:
P (Xi,s) =
n∏
i=1
xi,sP (Xi,s = 1) + (1− xi,s)P (Xi,s = 0) (22)
where n corresponds to the number of samples taken from each species and xi,s corresponds
to individual draws from the data X. The likelihood of the data X from individual i and
species s was generated from a Bernoulli distribution with success probability P , i.e.
probability of getting a seropositive individual upon testing, such that:
Xi,s ∼ Bernoulli(P (Xi,s = 1)) (23)
Where Xs = 1 corresponds to a CDV positive titer and Xs = 0 to a CDV negative titer.
If both realisations are equally likely, P (Xs = 1) = P (Xs = 0) = 0.5.
Prior sensitivity
We explored the sensitivity of the model results to the prior distributions by constrain-
ing and widening the allocated distribution range. The posterior distributions for most
parameters and the annual proportion of infected individuals hs(t) remained similar, sug-
gesting that the parameter estimates are not sensitive to the priors chosen (Tables S2-4).
Wider priors for q+ and q− generated convergence issues, but (i) given that these were
highly constrained to account for the knowledge that there is a low probability of false
detection and high probability of correct detection; and (ii) given that the overall hs(t)
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pattern remained largely unchanged; we find our results robust. The posterior distribu-
tions for the cross-species transmission terms were sensitive to wide priors (e.g. ∼ exp(10))
but these are not thought to be plausible values for these parameters. These posterior
distributions were not sensitive to the small changes in the priors (e.g. mean 0.2 to 2).
Model fit, convergence and sensitivity analysis
Both models were fitted using JAGS software (22) which uses Gibbs sampling to generate
posterior distributions of the parameters given the likelihood, prior distributions and the
data itself. We ran our models for at least 50 · 104 iterations with burn-in of 25 · 104
to achieve convergence. The models from which we draw inferences are the ones that
address our full set of scientific questions and both converged well and generate validated
fits. To ensure these models perform well, we evaluate the numerical robustness in the
form of convergence and mixing criteria (e.g. visual inspection of the chains, as well as
the Gelman-Rubin statistics [14,15] shown in Table S5 and S6) and goodness-of-fit, by,
for example, validating the posteriors against the priors and comparing the observed with
the estimated values.
We used a forward prediction approach to investigate the (1) effect of regional-level vac-
cination on the annual proportion of infected domestic dogs, and of the presence of cross-
species transmission from (2) lions-to-dogs and (3) dogs-to-lions on their respective annual
proportion of infected individuals (hs(t)). To ascertain the predictive power of the model,
we compared the estimates from equation 3 (i.e. infection hazard of dogs at time t) with
its prediction estimates (Figure S3). These results shows that the median and credible in-
tervals of the estimate (grey) and prediction (red) are very similar. This suggests a good
predictive power of at least the mean of the hazard. Consequently, model predictions
were generated from Equations 3 and 4 and these were compared to those in which the
parameter of interests (e.g. ω5 for vaccination, β4 for dog-to-lions and ω4 for lion-to-dogs
transmission) were set to zero.
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Figure S3: Comparison between the mean and 95% credible intervals of the estimated
(grey) and predicted dog probability of infection (red) from the CPV dynamics model
S3. JAGS code
The JAGS code for the two models can be found in a separate supplementary file associ-
ated with this submission.
Note: Ntime (total number of years in time-series), Ndogs and Nlions (total of number
of dogs and lions sampled respectively), V regional (regional-level vaccination coverage;
i.e. proportion of vaccinated villages per year), Coverage (village-level vaccination cov-
erage), Birth sp (year of birth of each individual i, sp corresponding to dogs or lions),
Sample sp (year when the serum sample of individual i was collected), and titer (titre
binary result where 1 indicates positive for CDV infection and 0 indicates negative) cor-
respond to available data.
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S4. Results
As indicated by the normal posteriors distributions, the models investigated converged
well. In addition, Tables S5-6 show the parameter values resulting from the models and
the estimated shrink factor values of the Gelman-Rubin convergence diagnostic. If both
the estimated value and the upper credible interval of the shrink factor are close to 1, the
chains are considered to have converged. As a rule of thumb, a model is considered to be
appropriate if approximately 80% of the parameter estimates converged well [16].
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Figure S4: Histograms of the prior distributions (red) and posterior distributions (grey)
of the domestic-wildlife interface model.
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Figure S5: Histograms of the prior distributions (red) and posterior distributions (grey)
of the co-infection in dogs model.
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Table S5: Median posterior estimates with associated 95% credible intervals (CI) and
Gelman-Rubin shrink factor (estimated value [upper CI]) of the domestic-wildlife interface
model.
Species Variable Param. Median (95% CI) Shrink factor
Lions Intercept β0 -11.818 (-40.65, 15.19) 1.02 [1.10]
Linear trend β1 -0.039 (-0.840, 0.788 ) 1.02 [1.12]
AR(1) β2 -0.246 (-1.125, 0.381 ) 1.00 [1.01]
AR(2) β3 -0.567 (-1.013, 0.129) 1.01 [1.02]
Dog-to-lion transmission β4 0.580 (0.019, 3.277) 1.02 [1.09]
Correct detection q+ 0.966 (0.798, 1.00) 1.01 [1.03]
False detection q− 1.545·10−2 1.00 [1.01]
(2.77·10−5, 9.71·10−2)
Dogs Intercept ω0 -19.02 (-39.33, -6.09) 1.06 [1.18]
Linear trend ω1 0.557 (0.188, 1.153) 1.07 [1.19]
AR(1) ω2 -0.334 (-1.24, 0.580) 1.06 [1.24]
AR(2) ω3 -0.312 (-0.799, 0.311) 1.00 [1.01]
Lion-to-dog transmission ω4 0.072 (0.003, 0.324) 1.00 [1.02]
Regional vacc. (lag 1) ω5 1.71 (0.071, 7.63) 1.00 [1.00]
Shedding parameter v1 0.193 (0.105, 0.407) 1.00 [1.00]
Correct detection q+ 0.914 (0.87, 0.95) 1.00 [1.00]
False detection q− 4.19·10−3 1.01 [1.03]
(1.09·10−5, 4.00·10−2)
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Table S6: Median posterior estimates with associated 95% credible intervals (CI) and
Gelman-Rubin shrink factor (estimated value [upper CI]) of the co-infection model.
Disease Variable Param. Median (95% CI) Shrink factor
CPV Intercept β0 -7.974 (-19.44, -1.17) 1.11 [1.39]
Linear trend β1 0.570 (0.104, 1.180 ) 1.03 [1.24]
AR(1) β2 -0.162 (-0.840, 0.549 ) 1.04 [1.10]
AR(2) β3 -0.171 (-0.721, 0.315) 1.10 [1.38]
CDV-to-CPV transmis-
sion
β4 0.255 (-0.137, 0.687) 1.70 [3.00]
Regional vacc. (lag 1) β5 0.98 (-4.83, 9.50) 1.09 [1.35]
Shedding parameter v1 0.188 (0.104, 0.39) 1.00 [1.00]
Correct detection q+ 0.973 (0.917, 1.00) 1.05 [1.22]
False detection q− 3.11·10−3 1.05 [1.16]
(8.56·10−6, 5.61·10−2)
CDV Intercept ω0 -10.97 (-28.63, 4.82) 1.11 [1.37]
Linear trend ω1 -0.114 (-0.97, 0.91) 1.12 [1.42]
AR(1) ω2 -0.348 (-1.03, 0.27) 1.02 [1.05]
AR(2) ω3 -0.063 (-0.74, 0.707) 1.06 [1.22]
CPV-to-CDV transmis-
sion
ω4 0.201 (-2.08, 1.93) 1.09 [1.32]
Regional vacc. (lag 1) ω5 -1.28 (-12.66, 9.66) 1.02 [1.07]
Correct detection q+ 0.960 (0.85, 1.00) 1.47 [3.08]
False detection q− 8.73·10−4 1.15 [1.54]
(2.54·10−6, 5.22·10−3)
Both Independent infections γ0 -1.787 (-4.504, 7.05) 2.17 [4.33]
CPV-to-coinfection γ1 4.098 (0.673, 9.041) 2.17 [4.40]
CDV-to-coinfection γ2 2.98 (-1.30, 8.17) 1.04 [1.15]
Correct detection q+ 0.989 (0.92, 1.00) 1.10 [1.30]
False detection q− 2.691·10−4 1.04 [1.07]
(8.14·10−7, 2.65·10−3)
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Comparison of the estimated temporal profiles and the observed data
Fig. S6 shows the estimated CPV temporal profiles for the dogs and the lions, overlaid
on the observed data. Despite the large confidence intervals as well as the small sample
size (in particular for the lions, as seen with the standard error bars in fig. S6), our model
is able to properly determine the temporal position of the peaks of infection.
Our results also show that our model is capable to capture the general trend of CPV
infection for both the lions and the dogs, inferring the temporal profile for periods of time
when no data is available (cf dogs between 1998 and 2002).
Figure S6: Estimated and observed CPV temporal profiles. a) Mean estimated annual
probability of CPV infection (solid line) and observed prevalence (dotted line) in dogs. b)
Mean estimated annual probability of CPV infection (solid line) and observed prevalence
(dotted line) in lions. Associated 50%, 75% and 95% credible intervals shown in increas-
ingly lighter colour shading. The vertical lines correspond to the standard error for the
observed prevalence.
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Age-seroprevalence profiles
Age-seroprevalence temporal profiles were generated for lions and dogs from the data to
clarify the potential peaks of infection. In Fig. S7 and Fig. S8 each curve corresponds to
a different sampling period, and represents seroprevalence in the birth year, as opposed
to the sampling year. This attempts to capture the fact that animals born after a peak
of infection will likely only get infected during the next peak. Thus for a given sampling
period, if the youngest age-class presents a low seroprevalence, it suggests that they were
born after an outbreak. If in a directly following sampling period, the lions born in
similar years present a high prevalence, it suggests the outbreak occurred between those
two sampling periods.
For example, we show that for the 1984-1991 sampling period, lions born between 1985
and 1990 present a very low sero-prevalence. However during the following sampling
period (1992-1995), the lions born in the same years (1985 to 1990) present a high sero-
prevalence. This clearly suggests that an outbreak occurred around 1991. Following the
same reasoning, CPV outbreaks in lions seem to have occurred around 1995 and around
2001.
In the case of endemic infection, we wouldn’t observe any peak, since the infection would
be constant in time. In that scenario, the age-seroprevalence curves would be constant, or
at least show limited variations corresponding to the absence of marked peaks of infection.
On the opposite, fig. S8 presents systematic decreases in sero-prevalence at the end of
each sampling period, suggesting the presence of peaks of infection followed by periods
of low infection. These results thus support the hypothesis of non-endemic infection in
lions.
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Figure S7: Dog age-seroprevalence temporal profiles. From top to bottom, panels corre-
spond to data sampled between 1984-1991, 1992-1995, 1996-2001, 2002-2007 and 2008-
2012. The number indicate the sample sizes for each point.
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Figure S8: Lion age-seroprevalence temporal profiles. From top to bottom, panels cor-
respond to data sampled between 1984-1991, 1992-1995, 1996-2001, 2002-2007 and 2008-
2012. The number indicate the sample sizes for each point.
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Cyclicity of CPV in lions and dogs
A Royama triangle is used to identify cyclicity in a time-series generated from an au-
toregressive process (Figure S9). If the estimated AR1 and AR2 coefficients fall outside
the triangle when plotted against each other, it indicates unstable dynamics that become
extinct. Inside the triangle, the dynamics are stable or display damped oscillations. In
addition, if the parameters fall within the parabola, the dynamics are deemed cyclic with
the period increasing from left to right as represented by the contour lines. Our results
(Figure S9) shows that CPV dynamics are cyclic in both species, with a period of ∼3 to
4 years between peaks of infection.
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Figure S9: AR parameter plane. Closed dark dots correspond to the posterior median of
the first-order AR coefficient [x-axis, AR (1)] of model 2 (i.e.,ω2/β2) against the posterior
median of the second-order AR coefficient [y-axis, AR (2)] (i.e., ω2/β2) for dogs (black)
and lions (blue), respectively. Each open light dot corresponds to a draw of the AR
posterior distributions.
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Dynamics of CPV in Dogs without shedding
Figure S10a shows that without including shedding, the model for CPV infection in
domestic dogs predicts higher probabilities of infection (since it combined the natural and
vaccine shed infection) but with similar dynamics. Moreover, vaccination can decrease the
annual proability of CPV infection, as shown in S10b. In particular, we note an increase
of the difference with/without vaccination after 2003, when the vaccination effort is more
important.
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Figure S10: a) Median annual probability of CPV infection in domestic dogs (full line)
and vaccination coverage (red). b) Mean (full line) and median (grey dotted line) dif-
ference between the estimated prediction of the annual probability of CPV infection and
the predicted annual probability of CPV infection without the vaccination effect. Asso-
ciated 50%, 75% and 95% credible intervals shown in increasingly lighter colour shading.
Vaccination coverage shown in red.
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Influence of CPV on co-infection dynamics and effect of vaccination.
The influence of both CDV and CPV on the co-infection dynamics starts decreasing in
2003 (Fig. 5, main text). This suggests that the vaccination effort, which increases in
2003, might have decoupled both diseases. This result is further confirmed when we
compare the estimated probability of being infected by CPV and CDV (pboth) to the
theoretical probability in the case where both diseases are independent, which is simply
the product of both probabilities pCDV ∗ pCPV (fig. S11). This difference is negative until
2005 when it starts increasing, which means that before 2005, more dogs are positive to
both diseases than expected when we consider both the diseases separately. However after
2005 (fig.S11, vertical dashed line), this trend is reversed: the increase in the vaccination
efforts tends to decouple the two diseases.
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Figure S11: Mean difference between the estimated probability of being infected by both
diseases and the probability of infection under strict independence of CPV and CDV (grey
line). Credible intervals (95, 75 and 50%) shown in increasing lighter shades of grey.
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